The Board of Directors of Jubilant Pharmova Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.
Jubilant HollisterStier, has received approval from the Government of Canada to provide, through its SIF program, a partially repayable loan of CAD 23.8 million to fund the CAD 108 million capacity expansion at the Montreal manufacturing facility.
The USFDA has assigned the inspection classification of the API facility as Voluntary Action Indicated pursuant to its inspection at the API manufacturing facility of Jubilant Pharmova Ltd at Nanjangud during 05-13 December 2022.
Data Bridge Market research has recently released expansive research titled Contract Manufacturing Market which guarantees you will remain better informed
Jubilant Bhartia Group, a global leader in pharma- and Life Science announced that it will establish a state-of-the-art facility in Hyderabad, India to benefit from the extraordinary talent pool of the city.